View the presentation >>| Listen to the recording >>
May 05, 2016
1:00 PM - 2:00 PM ET
Please join us for a regulatory, intellectual property, and business strategy review of the latest issues affecting companion diagnostics and how they will influence pharmaceutical, biotech, and medical device decisionmakers going forward.
This one-hour webinar will focus on issues for diagnostic and biomarker companies, pharma, and others with an interest in personalized medicine in the life sciences field.
Topics will include:
CLE credit: CLE credit in CA, FL, IL, NJ (via reciprocity), NY, PA, TX, and VA is currently pending approval.